Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) bringing about elevated adverse effects for example drowsiness, although the clinical relevance is reduced in most patients – monitor the patient for adverse effects (e. If affected person cannot resume their typical oral medicatio